Catabolism of phosphoinositides after treatment with opioid agonist phenaridin and its antagonist in brain synaptosomes of albion rats in vitro
Vartanian, G.S.; Agadzhanov, M.I.; Tadevosian, I.U.; Batikian, T.B.
Biulleten' Eksperimental'noi Biologii i Meditsiny 122(10): 405-406
1996
ISSN/ISBN: 0365-9615 PMID: 9081437 Document Number: 464699
Document emailed within 1 workday
Related Documents
Bot, G.; Blake, A.D.; Li, S.; Reisine, T. 1998: Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist Journal of Pharmacology and Experimental Therapeutics 284(1): 283-290Uzbekov, M.G. 1986: Tryptophan-5-hydroxylase activity in the rabbit brain synaptosomes at different times after the single administration of the opioid peptide Tyr-D-Ala-Gly-Phe-NH2 Biulleten' Eksperimental'noi Biologii i Meditsiny 101(2): 159-160
Rodina, V.I.; Salata, L.K.; Rozhanets, V.V.; Pozdniakov, O.M.; Glebov, R.N. 1980: Ultrastructural and functional changes in the synaptosomes of the rat brain on in vitro electrostimulation Biulleten' Eksperimental'noi Biologii i Meditsiny 89(2): 143-145
Verberne, A.J.; Louis, W.J. 1989: Interaction between the cardiovascular effects of clonidine and the kappa-opioid agonist U-50,488H in the anterior hypothalamic area of the rat brain Journal of Pharmacy and Pharmacology 41(2): 131-133
Lemcke, P.K.; Sugg, E.; Malarchik, M.; Lui, G.; Serra, M.; Yamamura, H.I.; Hruby, V.J.; Shook, J.E.; Burks, T.F. 1987: N-terminal cyclization of a nonsulfated CCK analogue exhibits opioid antagonist activity in vitro Proceedings of the Western Pharmacology Society 30: 223-226
Monti, J.M.; Fernández, M.; Jantos, H. 1990: Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 3(3): 153-162
Lindborg, B.; Crona, K.; Dahlbom, R.; Ross, S.B. 1984: Troxonium-like inhibitors of the high affinity uptake of choline in mouse brain synaptosomes in vitro Acta Pharmaceutica Suecica 21(5): 271-294
Fomenko, A.I.; Chichkovskaia, G.V.; Parkhomets, P.K.; Donchenko, G.V.; Stepanenko, S.P.; Khalmuradov, A.A. 1992: The functional characteristics of the inhibitory mediator systems in the brain synaptosomes of PP vitamin-deficient rats Ukrainskii Biokhimicheskii Zhurnal 64(6): 109-113
Tiniakova, L.R.; Antonikov, I.M.; Glebov, R.N. 1989: Effect of the Ca ionophore A-23187 on the plasmatic and mitochondrial potentials of the brain synaptosomes in rats: fluorescence measurements Biulleten' Eksperimental'noi Biologii i Meditsiny 107(6): 678-680
Kravtsov, G.M.; Orlov, S.N.; Pokudin, N.I.; Postnov, I.V. 1982: Characteristics of calcium and sodium transport in the synaptosomes and subsynaptosomal structures of the brain of spontaneously hypertensive rats Kardiologiia 22(11): 88-95
Devi, S.L.; Kannappan, S.; Anuradha, C.V. 2007: Evaluation of in vitro antioxidant activity of Indian bay leaf, Cinnamomum tamala (Buch. -Ham.) T. Nees and Eberm using rat brain synaptosomes as model system Indian Journal of Experimental Biology 45(9): 778-784
Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Rodríguez de Fonseca, F.; Rubio, P.; Menzaghi, F.; Merlo-Pich, E.; Rivier, J.; Koob, G.F.; Navarro, M. 1996: Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats Journal of Pharmacology and Experimental Therapeutics 276(1): 56-64
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Banerjee, J.; Banerjee, S.; Adhikari, J. 1989: Phosphoinositides from human foetal brain during development Journal of the Indian Medical Association 87(1): 6-8
Werling, L.L.; Brown, S.R.; Puttfarcken, P.; Cox, B.M. 1986: Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes Molecular Pharmacology 30(2): 90-95
Silva, C.; Mor, M.; Bordi, F.; Rivara, S.; Caretta, A.; Ballabeni, V.; Barocelli, E.; Plazzi, P.V. 1997: Plasma concentration and brain penetration of the H3-receptor antagonist thioperamide in rats Farmaco 52(6-7): 457-462
Pivovarchik, M.V. 2004: Change of dopamine, serotonin and opioid neuromediator systems in the brain of rats adapted to prolonged effect of ethanol Ukrains'kyi Biokhimichnyi Zhurnal 76(2): 93-97
Chen, X.H.; Geller, E.B.; Adler, M.W. 1996: Electrical stimulation at traditional acupuncture sites in periphery produces brain opioid-receptor-mediated antinociception in rats Journal of Pharmacology and Experimental Therapeutics 277(2): 654-660
Lôo, H.; Daléry, J.; Macher, J.P.; Payen, A. 2003: Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders L'Encephale 29(2): 165-171